846 related articles for article (PubMed ID: 14971932)
41. Beta-hairpin formation in aqueous solution and in the presence of trifluoroethanol: a (1)H and (13)C nuclear magnetic resonance conformational study of designed peptides.
Santiveri CM; Pantoja-Uceda D; Rico M; Jiménez MA
Biopolymers; 2005 Oct; 79(3):150-62. PubMed ID: 16078190
[TBL] [Abstract][Full Text] [Related]
42. The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta.
He W; Barrow CJ
Biochemistry; 1999 Aug; 38(33):10871-7. PubMed ID: 10451383
[TBL] [Abstract][Full Text] [Related]
43. Conformational transition of amyloid beta-peptide.
Xu Y; Shen J; Luo X; Zhu W; Chen K; Ma J; Jiang H
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5403-7. PubMed ID: 15800039
[TBL] [Abstract][Full Text] [Related]
44. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
Hou L; Zagorski MG
J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
[TBL] [Abstract][Full Text] [Related]
45. Misfolding of the amyloid beta-protein: a molecular dynamics study.
Flöck D; Colacino S; Colombo G; Di Nola A
Proteins; 2006 Jan; 62(1):183-92. PubMed ID: 16294338
[TBL] [Abstract][Full Text] [Related]
46. Mediating molecular recognition by methionine oxidation: conformational switching by oxidation of methionine in the carboxyl-terminal domain of calmodulin.
Anbanandam A; Bieber Urbauer RJ; Bartlett RK; Smallwood HS; Squier TC; Urbauer JL
Biochemistry; 2005 Jul; 44(27):9486-96. PubMed ID: 15996103
[TBL] [Abstract][Full Text] [Related]
47. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
Dong J; Atwood CS; Anderson VE; Siedlak SL; Smith MA; Perry G; Carey PR
Biochemistry; 2003 Mar; 42(10):2768-73. PubMed ID: 12627941
[TBL] [Abstract][Full Text] [Related]
48. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
Milojevic J; Esposito V; Das R; Melacini G
J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
[TBL] [Abstract][Full Text] [Related]
49. Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry.
Skribanek Z; Baláspiri L; Mák M
J Mass Spectrom; 2001 Nov; 36(11):1226-9. PubMed ID: 11747119
[TBL] [Abstract][Full Text] [Related]
50. Thermodynamics and dynamics of amyloid peptide oligomerization are sequence dependent.
Lu Y; Derreumaux P; Guo Z; Mousseau N; Wei G
Proteins; 2009 Jun; 75(4):954-63. PubMed ID: 19089954
[TBL] [Abstract][Full Text] [Related]
51. Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques.
Rodziewicz-Motowidło S; Juszczyk P; Kołodziejczyk AS; Sikorska E; Skwierawska A; Oleszczuk M; Grzonka Z
Biopolymers; 2007 Sep; 87(1):23-39. PubMed ID: 17534931
[TBL] [Abstract][Full Text] [Related]
52. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
Shivaprasad S; Wetzel R
Biochemistry; 2004 Dec; 43(49):15310-7. PubMed ID: 15581343
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylation-induced structural changes in the amyloid precursor protein cytoplasmic tail detected by NMR.
Ramelot TA; Nicholson LK
J Mol Biol; 2001 Mar; 307(3):871-84. PubMed ID: 11273707
[TBL] [Abstract][Full Text] [Related]
54. Free radical reactions of methionine in peptides: mechanisms relevant to beta-amyloid oxidation and Alzheimer's disease.
Schöneich C; Pogocki D; Hug GL; Bobrowski K
J Am Chem Soc; 2003 Nov; 125(45):13700-13. PubMed ID: 14599209
[TBL] [Abstract][Full Text] [Related]
55. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
Zagorski MG; Barrow CJ
Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
[TBL] [Abstract][Full Text] [Related]
56. Differential effects of Phe19 and Phe20 on fibril formation by amyloidogenic peptide A beta 16-22 (Ac-KLVFFAE-NH2).
Inouye H; Gleason KA; Zhang D; Decatur SM; Kirschner DA
Proteins; 2010 Aug; 78(10):2306-21. PubMed ID: 20544966
[TBL] [Abstract][Full Text] [Related]
57. Structural characterization of a soluble amyloid beta-peptide oligomer.
Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
[TBL] [Abstract][Full Text] [Related]
58. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
Dong X; Chen W; Mousseau N; Derreumaux P
J Chem Phys; 2008 Mar; 128(12):125108. PubMed ID: 18376983
[TBL] [Abstract][Full Text] [Related]
59. Interaction of a beta-sheet breaker peptide with lipid membranes.
Vitiello G; Grimaldi M; Ramunno A; Ortona O; De Martino G; D'Ursi AM; D'Errico G
J Pept Sci; 2010 Feb; 16(2):115-22. PubMed ID: 20063331
[TBL] [Abstract][Full Text] [Related]
60. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
Benseny-Cases N; Cócera M; Cladera J
Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
